ES8604589A1 - Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina - Google Patents

Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina

Info

Publication number
ES8604589A1
ES8604589A1 ES534259A ES534259A ES8604589A1 ES 8604589 A1 ES8604589 A1 ES 8604589A1 ES 534259 A ES534259 A ES 534259A ES 534259 A ES534259 A ES 534259A ES 8604589 A1 ES8604589 A1 ES 8604589A1
Authority
ES
Spain
Prior art keywords
pirimidina
procedure
preparing new
new imidazo
imidazo derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534259A
Other languages
English (en)
Spanish (es)
Other versions
ES534259A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of ES534259A0 publication Critical patent/ES534259A0/es
Publication of ES8604589A1 publication Critical patent/ES8604589A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES534259A 1983-07-12 1984-07-12 Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina Expired ES8604589A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58126697A JPS6019789A (ja) 1983-07-12 1983-07-12 イミダゾ〔１，５−ａ〕ピリミジン誘導体

Publications (2)

Publication Number Publication Date
ES534259A0 ES534259A0 (es) 1986-02-01
ES8604589A1 true ES8604589A1 (es) 1986-02-01

Family

ID=14941605

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534259A Expired ES8604589A1 (es) 1983-07-12 1984-07-12 Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina

Country Status (9)

Country Link
US (1) US4649198A (enExample)
EP (1) EP0134928B1 (enExample)
JP (1) JPS6019789A (enExample)
KR (1) KR910005850B1 (enExample)
AU (1) AU563849B2 (enExample)
CA (1) CA1238045A (enExample)
DE (1) DE3469177D1 (enExample)
DK (1) DK339584A (enExample)
ES (1) ES8604589A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143191A (ja) * 1984-08-07 1986-03-01 Kyorin Pharmaceut Co Ltd イミダゾ〔１，５−ａ〕ピリミジン誘導体
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
WO2003094839A2 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
US20050234080A1 (en) * 2002-05-23 2005-10-20 Coleman Paul J Mitotic kinesin inhibitors
KR20100110378A (ko) * 2002-05-24 2010-10-12 안지오테크 인터내셔날 아게 의료용 임플란트를 피복하기 위한 조성물 및 방법
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
WO2004114655A1 (en) * 2003-06-18 2004-12-29 Thomson Licensing S.A. Apparatus for recording data on motion picture film
EP1697331A4 (en) 2003-12-19 2010-08-04 Merck Sharp & Dohme INHIBITORS OF MITOTIC KINESINE
TW202214642A (zh) * 2020-07-02 2022-04-16 大陸商江蘇恆瑞醫藥股份有限公司 咪唑并嘧啶類衍生物、其製備方法及其在醫藥上的應用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2160020A1 (de) * 1971-12-03 1973-06-07 Bayer Ag Perchlor-imidazo-pyrimidin, verfahren zu seiner herstellung, sowie seine verwendung als fungizid
US3923808A (en) * 1972-12-08 1975-12-02 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US4178449A (en) * 1978-04-17 1979-12-11 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4408047A (en) * 1980-03-28 1983-10-04 Merck & Co., Inc. Imidazodiazines

Also Published As

Publication number Publication date
AU2937184A (en) 1985-01-17
DE3469177D1 (en) 1988-03-10
AU563849B2 (en) 1987-07-23
EP0134928A1 (en) 1985-03-27
DK339584D0 (da) 1984-07-11
ES534259A0 (es) 1986-02-01
KR850001213A (ko) 1985-03-16
JPH0450315B2 (enExample) 1992-08-13
US4649198A (en) 1987-03-10
JPS6019789A (ja) 1985-01-31
KR910005850B1 (ko) 1991-08-05
CA1238045A (en) 1988-06-14
DK339584A (da) 1985-01-13
EP0134928B1 (en) 1988-02-03

Similar Documents

Publication Publication Date Title
DE3468878D1 (en) 7-amino-azoloû1,5-a¨pyrimidines and fungicides containing them
AR241910A1 (es) Procedimiento para preparar derivados de 1-heteroaril-4-(2,5-pirrolidindion-1-il)-piperazina y sus sales.
ES8604589A1 (es) Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina
ES521952A0 (es) Un procedimiento para preparar derivados de androsteno.
ES533653A0 (es) Procedimiento para preparar pirazol(aril)metanonas
PT81860A (en) Process for preparing pyridopyrimidines useful as medicaments
DK262485A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
ZA868665B (en) Amino acid derivatives
RO87707A (ro) Procedeu pentru prepararea unor saruri de piridiniu
AU8114387A (en) Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression
IE902014L (en) Use of naftopidil for treating dysuric
ES2012578A6 (es) Procedimiento para preparar la sal de trometamina de 1-metil-beta-oxo-alfa- (fenilcarbamoil)-2-pirrolpropiontrilo.
ES552546A0 (es) Procedimiento para preparar derivados de pirazol-(1,5-a)piridina
ES508415A0 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ES482280A1 (es) Un procedimiento para la preparacion de nuevos derivados 2- (1h-imidazol-1-il)etoxi de pirazolo-3,4-b-piridina-5-metano-les.
DK433882A (da) 1,2,3-thiadiazol-5-yl-urinstofderivater, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse forbindelser med vaekstregulerende og afbladende virkning
AU576659B2 (en) 5-sulphonamido-1-aryl-pyrazoles
ES8604174A1 (es) Procedimiento para la obtencion de isoxazoles
DK433782A (da) 1,2,3-thiadiazol-5-yl-urinstofderivater, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse forbindelser med vaekstregulerende, afbladende virkning
FR2511376B1 (enExample)
PT83003B (pt) Metodo para a utilizacao de derivados heterociclicos de pentaleno no combate a microorganismos
AU550191B2 (en) Imidazo (2,1-b)thiazoles, and thiazolo (3,2-a)-pyrimidine derivatives
DE3662892D1 (en) Bisthiol phosphates, process for their preparation, their use as pesticides and agents therefor
IT8867714A0 (it) Procedimento per il trattamento di fanghi di verniciatura
IE871808L (en) {2-£amino-pyridinyl) amino| phenyl} derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401